Riverside invests in HealthTech BioActives
The Riverside Company, a global private equity firm focused on the smaller end of the middle market, has invested in HealthTech BioActives (HTBA). HTBA is a Spanish manufacturer of active pharmaceutical ingredients (APIs), excipients, flavourings and sweeteners for the pharmaceutical, nutraceutical and cosmetic industries, as well as ingredients for human